Tensions continue to rise between Xavier Woods and Kofi Kingston. On the September 16 episode of WWE RAW, The New Day (Woods ...

In a recent interview, former WWE Women’s World Champion Rhea Ripley revealed she was heartbroken over being removed from Judgement Day. The Bloodline has garnered a huge amount of attention ...

To coincide with World Amazon Day, we’d like to invite you to get to know more about ... A Hidden Amazon World Of Communication And Harmony In the Colombian Amazon, WWF has been collaborating with ...

The Judgment Day has gone through several changes over the past few weeks after Dominik Mysterio betrayed Rhea Ripley and Finn Balor turned his back on Damian Priest at WWE SummerSlam. Carlito and ...

Besides the second story in my rundown, the Judgment Day was the biggest story coming into Raw. SummerSlam left everything in disarray with Damian Priest and Rhea Ripley seemingly on the outs.

The Judgment Day continues to be a dominant force even after the oldest members, Rhea Ripley and Damian Priest, were kicked out. A member of the heel faction recently took to Instagram to share a ...

The Judgment Day’s Damian Priest, Finn Balor, Carlito and JD McDonagh walked in on Dominik Mysterio and Liv Morgan preparing for their tag team match vs. The LWO’s Rey Mysterio and Zelina Vega ...

Is Judgment Day better without Damian Priest and Rhea Ripley? This is a tough question to answer and depends upon how individuals perceive the group to be. While it’s commonly believed that ...

A new piece of WWE merchandise is turning heads for featuring a name for The Judgment Day that the company had previously backtracked on.

After the commercial break, Finn Balor and JD McDonagh of The Judgment Day made their way to the ringside. Their entry is announced by the famous commentator Samantha Irvin who first announces the ...

The New Day will challenge for the gold. On the September 9th episode of WWE Raw, Kofi Kingston told his New Day teammate Xavier Woods that he got them a shot at the WWE World Tag Team Championship on ...

Travere Therapeutics' stock has been volatile due to Filspari's failed Phase 3 trials, but a full FDA approval is possible next week that could boost its share price. Despite setbacks, Filspari's ...